In contrast, it was reported that immature DC infused precisely into tumor tissues also contributed to the recruitment and activation of immune cells such as IL-15 in situ, however, this approach by itself generated limited anti-tumor effects due to probably insufficient stimulation of immature DCs [63, 74] and had no effect on prolonged recurrence-free survival. This evidence concerns the gene IL15 and neoplasm.